D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DICE holding history
DICE Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DICE overviewAll 13F holders of DICEFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −323,453−100.0% | Sold out | Holders |
| Q2 2023 | 323,453 | $15.0M | <0.1% | −232,788−41.9% | Reduced | Holders |
| Q1 2023 | 556,241 | $15.9M | <0.1% | −126,693−18.6% | Reduced | Holders |
| Q4 2022 | 682,934 | $21.3M | <0.1% | +682,934 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,718−100.0% | Sold out | Holders |
| Q1 2022 | 10,718 | $205.0K | <0.1% | −53,428−83.3% | Reduced | Holders |
| Q4 2021 | 64,146 | $1.62M | <0.1% | +64,146 | New | Holders |